STOCK TITAN

Insider sale after RSU vesting — TARS (NASDAQ: TARS) files Form 144

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
144

Rhea-AI Filing Summary

TARS submitted a Form 144 notice reporting restricted stock vesting and related disposals of common shares. The filing lists 379 common shares tied to a Restricted Stock Vesting event on 03/17/2026. It also records that 375 common shares were sold during the past three months on 03/17/2026 by Elizabeth Yeu-Lin.

Positive

  • None.

Negative

  • None.

Insights

Routine Form 144 filing: restricted shares vested and a near-term disposition reported.

The filing documents a Restricted Stock Vesting event for 379 common shares dated 03/17/2026, and a reported sale of 375 shares on the same date by Elizabeth Yeu-Lin. This pattern is consistent with post-vesting transfers and Rule 144 dispositions.

Timing and cash-flow treatment are not specified beyond the sale date. Subsequent SEC filings may disclose additional transfers or confirmations; the reported figures should be verified against brokerage or company disclosures for settlement details.

144: Filer Information

144: Issuer Information

144: Securities Information



Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold


* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.



Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

144: Remarks and Signature

FAQ

What does TARS's Form 144 disclose about insider transactions?

It discloses a restricted stock vesting and a near-term sale of common shares dated 03/17/2026. The filing lists 379 shares tied to vesting and shows 375 shares sold by Elizabeth Yeu-Lin on 03/17/2026, indicating a disposition following vesting.

Who is the reporting person on the TARS Form 144?

The filing lists Elizabeth Yeu-Lin as the individual associated with the sale. The Form 144 shows her address and records a sale of 375 common shares on 03/17/2026, linked to the disclosed restricted stock vesting event.

How many shares vested and were sold according to the filing?

The document lists 379 common shares related to restricted stock vesting on 03/17/2026 and reports a sale of 375 shares on the same date. These are the explicit share counts recorded in the excerpt.

Does the Form 144 specify proceeds or settlement details for the sale?

No proceeds or settlement amounts are provided in the excerpt. The filing records the share counts and dates (03/17/2026) but does not state cash proceeds, prices, or settlement instructions for the reported sale.
Tarsus Pharmaceuticals, Inc.

NASDAQ:TARS

View TARS Stock Overview

TARS Rankings

TARS Latest News

TARS Latest SEC Filings

TARS Stock Data

2.75B
40.38M
Biotechnology
Biological Products, (no Diagnostic Substances)
Link
United States
IRVINE